- Investing Ideas
- /
- Swiss Undervalued based on future growth
Swiss Undervalued based on future growth
Results
4
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
4 companies
Cosmo Pharmaceuticals
Market Cap: CHF 994.6m
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 62.40
7D
-7.6%
1Y
-3.3%
Vetropack Holding
Market Cap: CHF 399.5m
Provides glass packaging products for the food and beverage industry.
VETN
CHF 20.15
7D
-6.1%
1Y
-28.2%
Newron Pharmaceuticals
Market Cap: CHF 283.4m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 14.20
7D
-1.7%
1Y
79.7%
lastminute.com
Market Cap: CHF 149.8m
Operates in the online travel industry providing dynamic holiday packages in Italy, Spain, the United Kingdom, France, Germany, and internationally.
LMN
CHF 14.05
7D
8.5%
1Y
-18.1%